During 20 years from 1989, we treated 50 patients with supraglottic squamous cell carcinoma with an adequately comprehensive combination of chemotherapy and radiation followed by surgery. The patients consisted of 39 men and 11 women, median age 69 years. According to the stage classification there were 8 cases with Stage I, 9 with Stage II, 14 with Stage III, 16 with Stage IVA, 2 with Stage IVB, and 1 with Stage IVC. Radiation was used for all 50 patients by conventional X-ray (median 66Gy) associated with chemotherapy (for 30 patients chiefly at stage III and IV) as induction chemotherapy (ICT) or concurrent chemoradiotherapy (CCRT) in which fluorouracil and carboplatin were administered. Radiation alone was used for 20 patients. If the efficacy of pre-operative treatment was insufficient at 46Gy of radiation, surgery was inevitable.
In this study, our paradigm of treatment for supraglottic carcinoma was retrospectively investigated by the probabilities of 5-year overall survival rate, 5-year cause-specific survival rate, and 5-year preservation rate of the larynx, which were 65.7%, 82.6% and 64.2%, respectively. Furthermore, the probabilities of 5-year survival rates for patients at T3 and T4 with intact larynx (75.5%) or after laryngectomy (75.0%) showed no statistically significant difference. At 2 years, the proportion of 33 patients at stage III and IV who had an intact larynx after concurrent chemoradiotherapy (83.3%) was not significantly different from the proportions in the groups given induction chemotherapy followed by radiation(80.0%)or radiation alone (87.5%). In the three therapeutic groups, 2-year cause-specific survival rates were also similar (77.8%, 37.5%, 64.8%), respectively.
View full abstract